Mirantis Names Co-Founder Alex Freedland to Succeed

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Mirantis Names Co-Founder Alex Freedland to Succeed Departing CEO

MOUNTAIN VIEW, CA--(Marketwired - Oct 1, 2015) - Mirantis, the pure-play OpenStack company, today announced that company chairman Alex Freeland will succeed Adrian Ionel as chief executive. Ionel, who joined Mirantis' founding team in 2009 and helped build the company into a global leader for cloud infrastructure, is leaving to launch a new venture. He will remain a board advisor and large shareholder.

Freedland, who co-founded Mirantis, most recently served as president of the company and oversaw the raising of $100 million in new investment funding led by Intel Capital.

"My six years at Mirantis have been a tremendous blessing and I'm very grateful for the opportunity to work with so many amazing colleagues," Ionel said. "Together we've built a company with a very bright future and I know Alex and the team will do a spectacular job taking it forward."

Freedland said Mirantis is ideally poised for the increasing adoption of open cloud infrastructure.

"With Adrian at the helm, Mirantis has become the leader in the open cloud movement," Freedland said. "We are one of the top two contributors of OpenStack and helped many leading Global 2000 enterprises successfully build and operate open clouds. It has been an amazing journey and I am very grateful to Adrian for getting us into the pole position for the mass adoption of the open cloud."

Freedland brings more than 20 years of executive management and community program leadership to Mirantis. A board member of the OpenStack Foundation since its inception, Freedland is a serial tech entrepreneur. In addition to most recently leading Mirantis' financial operations, he also oversaw the company's OpenStack software community contribution strategy.

"Alex brings a unique combination of a founder's passion, intimate understanding of the company culture and hands-on involvement with the OpenStack community," said Dharmesh Thakker, board member of Mirantis, and the former managing director of Cloud and Big Data at Intel Capital, who led the initial venture investment in Mirantis. "We are excited to see Mirantis, with Alex at the helm, guide Global 2000 enterprises on their journey to the open cloud." During his tenure as CEO, Ionel led Mirantis' investment in OpenStack and the company's growth from a handful of customers to more than 200 enterprises. The company established a worldwide presence and raised nearly a quarter billion dollars in investment.

Jeff Horing, managing director of Insight Venture Partners and a Mirantis board member, applauded Ionel for his service. "Adrian led Mirantis' growth into a global OpenStack software and solutions powerhouse," he said. "We're deeply grateful to him for laying the foundation for this hugely successful company. The executive team and board wish him well on his next venture."

About Mirantis Mirantis is the pure play OpenStack company . Mirantis delivers all the software , services , training , and support needed for running OpenStack. More customers rely on Mirantis than any other company to get to production deployment of OpenStack at scale. Mirantis is among the top three companies worldwide in contributing open source software to OpenStack, and has helped build and deploy some of the largest OpenStack clouds in the world, at companies such as Cisco, Comcast, Ericsson, NASA, Samsung and Symantec. Mirantis is venture-backed by August Capital, Ericsson, Goldman Sachs, Intel Capital, Insight Venture Partners, Sapphire Ventures, Sielgler & Guff and WestSummit Capital, with headquarters in Mountain View, California. Follow us on Twitter at @mirantisit .

Contact Information: Sarah Bennett PR manager Mirantis sbennett@mirantis.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading